Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202003743599701Phase 4Not yet recruiting
Phase 4 trial of emtricitabine + tenofovir disoproxil, sponsored by University of Washington. Planned start Feb 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202003743599701.